Skip to main content
. 2023 Nov 14;59(11):1997. doi: 10.3390/medicina59111997

Figure 4.

Figure 4

Schematic representation of different subgroups with respective therapy. CYC, cyclophosphamide; CNI, calcineurin inhibitors; RTX, rituximab.